Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 51 studies with search of: | "Fibrosarcoma" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
|
||||
2 | Recruiting |
Bevacizumab and Radiation Therapy for Sarcomas
|
||||
3 | Active, not recruiting |
Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
|
||||
4 | Active, not recruiting |
Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma
|
||||
5 | Recruiting |
Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung
|
||||
6 | Withdrawn |
Ifosfamide in Treating Patients With Meningeal Tumors
|
||||
7 | Active, not recruiting |
Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans (DFSP) or Transformed Fibrosarcomatous DFSP
|
||||
8 | Active, not recruiting |
Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma
|
||||
9 | Recruiting |
A Short Course of Neoadjuvant Gleevec (Imatinib Mesylate) in Dermatofibrosarcoma Protuberans
|
||||
10 | Recruiting |
Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
|
||||
11 | Recruiting |
Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans
|
||||
12 | Active, not recruiting |
Imatinib in Dermatofibrosarcoma Protuberans (DFSP)
|
||||
13 | Recruiting |
Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans
|
||||
14 | Active, not recruiting |
Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery
|
||||
15 | Recruiting |
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
|
||||
16 | Recruiting |
Monoclonal Antibody IMC-A12 and Doxorubicin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
|
||||
17 | Completed |
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
|
||||
18 | Recruiting |
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
|
||||
19 | Active, not recruiting |
Combination Chemotherapy in Treating Patients With Advanced Cancer
|
||||
20 | Active, not recruiting |
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |